These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 34125534)
1. Glitazones Activate PGC-1α Signaling via PPAR-γ: A Promising Strategy for Antiparkinsonism Therapeutics. P P; Justin A; Ananda Kumar TD; Chinaswamy M; Kumar BRP ACS Chem Neurosci; 2021 Jul; 12(13):2261-2272. PubMed ID: 34125534 [TBL] [Abstract][Full Text] [Related]
2. Rational Design, Synthesis, and In Vitro Neuroprotective Evaluation of Novel Glitazones for PGC-1α Activation via PPAR-γ: a New Therapeutic Strategy for Neurodegenerative Disorders. Justin A; Mandal S; Prabitha P; Dhivya S; Yuvaraj S; Kabadi P; Sekhar SJ; Sandhya CH; Wadhwani AD; Divakar S; Bharathi JJ; Durai P; Prashantha Kumar BR Neurotox Res; 2020 Mar; 37(3):508-524. PubMed ID: 31782098 [TBL] [Abstract][Full Text] [Related]
3. PPARγ and PGC-1α as therapeutic targets in Parkinson's. Corona JC; Duchen MR Neurochem Res; 2015 Feb; 40(2):308-16. PubMed ID: 25007880 [TBL] [Abstract][Full Text] [Related]
4. Peroxisom proliferator-activated receptor-γ coactivator-1α in neurodegenerative disorders: A promising therapeutic target. Yang YN; Zhang MQ; Yu FL; Han B; Bao MY; Yan-He ; Li X; Zhang Y Biochem Pharmacol; 2023 Sep; 215():115717. PubMed ID: 37516277 [TBL] [Abstract][Full Text] [Related]
5. Glitazones, PPAR-γ and Neuroprotection. Kumar AP; P P; Kumar BRP; Jeyarani V; Dhanabal SP; Justin A Mini Rev Med Chem; 2021; 21(12):1457-1464. PubMed ID: 33663364 [TBL] [Abstract][Full Text] [Related]
6. PGC-1α sparks the fire of neuroprotection against neurodegenerative disorders. Lv J; Jiang S; Yang Z; Hu W; Wang Z; Li T; Yang Y Ageing Res Rev; 2018 Jul; 44():8-21. PubMed ID: 29580918 [TBL] [Abstract][Full Text] [Related]
7. Combination of Peroxisome Proliferator-activated Receptor Gamma (PPARγ) Agonist and PPAR Gamma Co-Activator 1α (PGC-1α) Activator Ameliorates Cognitive Deficits, Oxidative Stress, and Inflammation in Rodent Model of Parkinson's Disease. Das NR; Vaidya B; Khare P; Bishnoi M; Sharma SS Curr Neurovasc Res; 2021; 18(5):497-507. PubMed ID: 34923943 [TBL] [Abstract][Full Text] [Related]
8. Advances in PPARs Molecular Dynamics and Glitazones as a Repurposing Therapeutic Strategy through Mitochondrial Redox Dynamics against Neurodegeneration. Durai P; Beeraka NM; Ramachandrappa HVP; Krishnan P; Gudur P; Raghavendra NM; Ravanappa PKB Curr Neuropharmacol; 2022; 20(5):893-915. PubMed ID: 34751120 [TBL] [Abstract][Full Text] [Related]
9. Thiazolidinediones and rexinoids induce peroxisome proliferator-activated receptor-coactivator (PGC)-1alpha gene transcription: an autoregulatory loop controls PGC-1alpha expression in adipocytes via peroxisome proliferator-activated receptor-gamma coactivation. Hondares E; Mora O; Yubero P; Rodriguez de la Concepción M; Iglesias R; Giralt M; Villarroya F Endocrinology; 2006 Jun; 147(6):2829-38. PubMed ID: 16513826 [TBL] [Abstract][Full Text] [Related]
10. Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha as a Novel Target for Bipolar Disorder and Other Neuropsychiatric Disorders. Nierenberg AA; Ghaznavi SA; Sande Mathias I; Ellard KK; Janos JA; Sylvia LG Biol Psychiatry; 2018 May; 83(9):761-769. PubMed ID: 29502862 [TBL] [Abstract][Full Text] [Related]
11. The role of PGC-1α in the pathogenesis of neurodegenerative disorders. Róna-Vörös K; Weydt P Curr Drug Targets; 2010 Oct; 11(10):1262-9. PubMed ID: 20840068 [TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor-γ (PPARγ) agonist is neuroprotective and stimulates PGC-1α expression and CREB phosphorylation in human dopaminergic neurons. Mäkelä J; Tselykh TV; Kukkonen JP; Eriksson O; Korhonen LT; Lindholm D Neuropharmacology; 2016 Mar; 102():266-75. PubMed ID: 26631533 [TBL] [Abstract][Full Text] [Related]
13. Deciphering the role of PGC-1α in neurological disorders: from mitochondrial dysfunction to synaptic failure. Panes JD; Wendt A; Ramirez-Molina O; Castro PA; Fuentealba J Neural Regen Res; 2022 Feb; 17(2):237-245. PubMed ID: 34269182 [TBL] [Abstract][Full Text] [Related]
15. Design and Development of Novel Glitazones for Activation of PGC-1α Signaling Via PPAR-γ Agonism: A Promising Therapeutic Approach against Parkinson's Disease. Prabhakaran P; Nadig A; M S; Tuladhar S; Raju RM; Chidambaram SB; Kempaiah BB; Raghavendra NM; Kumar Br P ACS Omega; 2023 Feb; 8(7):6825-6837. PubMed ID: 36844520 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of PGC-1α Influences Mitochondrial Signal Transduction of Dopaminergic Neurons. Ye Q; Huang W; Li D; Si E; Wang J; Wang Y; Chen C; Chen X Mol Neurobiol; 2016 Aug; 53(6):3756-3770. PubMed ID: 26141122 [TBL] [Abstract][Full Text] [Related]
17. Role of PGC-1α in Mitochondrial Quality Control in Neurodegenerative Diseases. Zhang Q; Lei YH; Zhou JP; Hou YY; Wan Z; Wang HL; Meng H Neurochem Res; 2019 Sep; 44(9):2031-2043. PubMed ID: 31410709 [TBL] [Abstract][Full Text] [Related]
18. Apelin-13 Improves Cognitive Impairment and Repairs Hippocampal Neuronal Damage by Activating PGC-1α/PPARγ Signaling. Chen B; Wu J; Hu S; Liu Q; Yang H; You Y Neurochem Res; 2023 May; 48(5):1504-1515. PubMed ID: 36512295 [TBL] [Abstract][Full Text] [Related]